Table 3

Maximum spinal cord dose and mean mandibular dose (Gray) in the study group and historical control group for oropharyngeal, oral cavity, and laryngeal-hypopharyngeal cancers
Site Spinal cord Mandibular
Study Control p value Study Control p value
Oropharynx 35.2 39.3 0.1 39.2 44.9 0.4
Oral cavity 33.6 36.9 0.1 55.4 57.2 0.4
Larynx and hypopharynx 34.2 36.1 0.5 30 31.8 0.8

Nguyen et al.

Nguyen et al. BMC Cancer 2012 12:175   doi:10.1186/1471-2407-12-175

Open Data